SCHEMBL7975372

SCHEMBL7975372

Cc1cccc(Cn2cnc(N)c2C(N)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
CYP11B1 P15538 2/20 0.51
CYP11B2 P19099 2/20 0.51
LMNA P02545 2/20 0.51
ADRA1D P25100 1/20 0.49
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
RECQL P46063 1/20 0.45
TSHR P16473 4/20 0.44
HPGD P15428 4/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
ALOX15 P16050 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989347 0.86 CYP11B1 (0.44) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7974026 0.84 KDM4E (0.58) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7974168 0.84 CDK9 (0.45) ALDH1A1CYP11B1CYP11B2TSHRSMN1; SMN2
SCHEMBL7988093 0.84 FYN (0.43) TSHRGAAPKMKMT2A
SCHEMBL7984239 0.84 ADRA1D (0.52) LMNAADRA1DADORA2AADORA1TP53
SCHEMBL7988530 0.83 SMN1; SMN2 (0.46) ALDH1A1CYP11B1CYP11B2LMNACYP1A2
SCHEMBL5483136 0.83 PKM (0.59) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
Hydrochloric Acid SCHEMBL7987445 0.82 PKM (0.57) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7974034 0.81 ATM (0.48) ALDH1A1LMNASMN1; SMN2TP53MAPT
SCHEMBL7987961 0.80 MAPT (0.47) ALDH1A1CYP11B1CYP11B2LMNAADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed